114 related articles for article (PubMed ID: 35734806)
21. Male breast cancer: Looking for better prognostic subgroups.
Abreu MH; Afonso N; Abreu PH; Menezes F; Lopes P; Henrique R; Pereira D; Lopes C
Breast; 2016 Apr; 26():18-24. PubMed ID: 27017238
[TBL] [Abstract][Full Text] [Related]
22. The expression and prognostic role of EBP1 and relationship with AR in HER2+ breast cancer.
Liu J; Xu C; Xu D; Cao L; Xue H; Meng Q; Niu Y
Virchows Arch; 2020 Aug; 477(2):279-289. PubMed ID: 32086588
[TBL] [Abstract][Full Text] [Related]
23. Ki67 expression in breast cancer. Correlation with prognostic markers and clinicopathological parameters in Saudi patients.
Elkablawy MA; Albasri AM; Mohammed RA; Hussainy AS; Nouh MM; Alhujaily AS
Saudi Med J; 2016 Feb; 37(2):137-41. PubMed ID: 26837394
[TBL] [Abstract][Full Text] [Related]
24. Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers.
Ogawa Y; Hai E; Matsumoto K; Ikeda K; Tokunaga S; Nagahara H; Sakurai K; Inoue T; Nishiguchi Y
Int J Clin Oncol; 2008 Oct; 13(5):431-5. PubMed ID: 18946753
[TBL] [Abstract][Full Text] [Related]
25. The prognostic value of androgen receptors in breast cancer subtypes.
Kraby MR; Valla M; Opdahl S; Haugen OA; Sawicka JE; Engstrøm MJ; Bofin AM
Breast Cancer Res Treat; 2018 Nov; 172(2):283-296. PubMed ID: 30109519
[TBL] [Abstract][Full Text] [Related]
26. Androgen Receptor Expression in ER and PR Negative Breast Cancer-A Study from a Tertiary Hospital in Northern India.
Sidhu S; Kwatra KS; Kinsley PA
South Asian J Cancer; 2023 Oct; 12(4):319-325. PubMed ID: 38130277
[TBL] [Abstract][Full Text] [Related]
27. Androgen receptor expression shows distinctive significance in ER positive and negative breast cancers.
Tsang JY; Ni YB; Chan SK; Shao MM; Law BK; Tan PH; Tse GM
Ann Surg Oncol; 2014 Jul; 21(7):2218-28. PubMed ID: 24639191
[TBL] [Abstract][Full Text] [Related]
28. Immunophenotyping of male breast cancer - Experience at a tertiary care centre.
Pasricha S; Kamboj M; Tanwar P; Gupta G; Panigrahi M; Sharma A; Durga G; Mehta A
Indian J Pathol Microbiol; 2019; 62(2):226-231. PubMed ID: 30971545
[TBL] [Abstract][Full Text] [Related]
29. Androgen Receptor Status in Triple Negative Breast Cancer: Does It Correlate with Clinicopathological Characteristics?
Dubrava AL; Kyaw PSP; Newman J; Pringle J; Westhuyzen J; La Hera Fuentes G; Shakespeare TP; Sakalkale R; Aherne NJ
Breast Cancer (Dove Med Press); 2023; 15():359-371. PubMed ID: 37197610
[TBL] [Abstract][Full Text] [Related]
30. Correlation of androgen receptor with ultrasound, clinicopathological features and clinical outcomes in breast cancer.
Zhang X; Cui H; Hu N; Han P; Fan W; Wang P; Zuo X; Zhao D; Huang H; Li S; Kong H; Peng F; Tian J; Zhang L
Insights Imaging; 2023 Mar; 14(1):46. PubMed ID: 36929229
[TBL] [Abstract][Full Text] [Related]
31. Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1-98.
Kensler KH; Regan MM; Heng YJ; Baker GM; Pyle ME; Schnitt SJ; Hazra A; Kammler R; Thürlimann B; Colleoni M; Viale G; Brown M; Tamimi RM
Breast Cancer Res; 2019 Feb; 21(1):30. PubMed ID: 30795773
[TBL] [Abstract][Full Text] [Related]
32. Expression of the androgen receptor and its correlation with molecular subtypes in 980 chinese breast cancer patients.
Qi JP; Yang YL; Zhu H; Wang J; Jia Y; Liu N; Song YJ; Zan LK; Zhang X; Zhou M; Gu YH; Liu T; Hicks DG; Tang P
Breast Cancer (Auckl); 2012; 6():1-8. PubMed ID: 22259247
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Role of Androgen Receptor Expression in Surgically Resected Early Breast Cancer Patients.
Yang Y; Min A; Lee KH; Ryu HS; Kim TY; Woo GU; Suh KJ; Lee DW; Lee HB; Moon HG; Han W; Park IA; Noh DY; Im SA
J Breast Cancer; 2020 Apr; 23(2):182-193. PubMed ID: 32395377
[TBL] [Abstract][Full Text] [Related]
34. A Phase II Study Evaluating Orteronel, an Inhibitor of Androgen Biosynthesis, in Patients With Androgen Receptor (AR)-Expressing Metastatic Breast Cancer (MBC).
Yardley DA; Young RR; Adelson KB; Silber AL; Najera JE; Daniel DB; Peacock N; Finney L; Hoekstra SJ; Shastry M; Hainsworth JD; Burris HA
Clin Breast Cancer; 2022 Apr; 22(3):269-278. PubMed ID: 34824002
[TBL] [Abstract][Full Text] [Related]
35. Metaplastic Breast Carcinoma: Clinicopathological Parameters and Prognostic Profile.
Haroon S; Zia S; Shirazi UA; Ahmed O; Asghar IA; Diwan MA; Afzal A; Irfan M; Ali SJ; Hashmi AA
Cureus; 2021 Apr; 13(4):e14347. PubMed ID: 33987039
[TBL] [Abstract][Full Text] [Related]
36. Differential impact of the expression of the androgen receptor by age in estrogen receptor-positive breast cancer.
Tokunaga E; Hisamatsu Y; Taketani K; Yamashita N; Akiyoshi S; Okada S; Tanaka K; Saeki H; Oki E; Aishima S; Oda Y; Morita M; Maehara Y
Cancer Med; 2013 Dec; 2(6):763-73. PubMed ID: 24403250
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Significance of High Androgen Receptor Expression in Prostatic Acinar Adenocarcinoma.
Hashmi AA; Mudassir G; Irfan M; Hussain ZF; Hashmi SK; Asif H; Nisar L; Naeem M; Faridi N
Asian Pac J Cancer Prev; 2019 Mar; 20(3):893-896. PubMed ID: 30912411
[TBL] [Abstract][Full Text] [Related]
38. The Expression and Prognostic Significance of Claudin-8 and Androgen Receptor in Breast Cancer.
Zhang Y; Zheng A; Lu H; Jin Z; Peng Z; Jin F
Onco Targets Ther; 2020; 13():3437-3448. PubMed ID: 32425547
[TBL] [Abstract][Full Text] [Related]
39. Age related influence of triple receptor status on metastatic breast cancer post relapse survival.
Todorovic-Rakovic N; Neskovic-Konstantinovic Z
J BUON; 2013; 18(4):851-8. PubMed ID: 24344008
[TBL] [Abstract][Full Text] [Related]
40. Androgen receptor and metastasis-associated protein-1 are frequently expressed in estrogen receptor negative/HER2 positive breast cancer.
Zhao L; Niu F; Shen H; Liu X; Chen L; Niu Y
Virchows Arch; 2016 Jun; 468(6):687-96. PubMed ID: 27026268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]